IP Library Granted Patent US 12,275,696
Granted Patent B2
US 12,275,696 · App. 18/164,309 · Granted Apr 15, 2025

Process for preparing tapinarof

Inventors: Ian Paul Andrews (King of Prussia, PA); Nicholas Calandra (Cambridge, MA); Tyler Andrew Davis (Research Triangle Park, NC); Ravinder Reddy Sudini (King of Prussia, PA)
Assignee: DERMAVANT SCIENCES GMBH
C07C39/08C07C37/002C07C37/07C07C45/54C07C45/63C07C45/72C07C50/24C07C51/09C07C51/38C07C59/353C07C67/03C07C67/293C07C67/343C07C69/716A61K31/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,275,696
App. No.
18/164,309
Granted
Apr 15, 2025
Kind
B2
Abstract

The present invention provides processes for the preparation of 3, 5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and novel intermediates used therein. In some embodiments the 3, 5-Dihydroxy-4-isopropyl-trans-stilbene is prepared from (E)-2-chloro-2-isopropyl-5-styrylcyclohexane-1,3-dione. Also disclosed are crystal forms of 3, 5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and pharmaceutical compositions comprising same.

Claims (33)

1. A process for the preparation of a compound of Formula (I) or a salt or solvate thereof

comprising one or more of the process steps (a), (b) and (c) wherein:

(a) comprises (i) reaction of a compound of Formula (III) or a salt thereof

to form a compound of Formula (II) or a salt thereof

wherein X is Cl, Br, or I, and thereafter (ii) conversion of the compound of Formula (II) or a salt thereof into the compound of Formula (I) or a salt or solvate thereof;

(b) comprises conversion of a compound of Formula (VI) or a salt thereof

into a compound of Formula (III) or a salt thereof

and thereafter conversion of the compound of Formula (III) or a salt thereof into a compound of Formula (I) or a salt or solvate thereof; and

(c) comprises conversion of a compound of Formula (IX) or a salt thereof

into a compound of Formula (VI) or a salt thereof

and thereafter conversion of the compound of Formula (VI) or a salt thereof into a compound of Formula (I) or a salt or solvate thereof.

2. The process according to claim 1 in which X is Cl and the process step (a) (i) is carried out using a chlorination reagent selected from the group consisting of 1,3-dichloro-5,5-dimethylhydantoin, N-chlorosuccinimide and trichloroisocyanuric acid.

3. The process according to claim 1 wherein the conversion step (a) (ii) is carried out in the presence of an additive reagent which is a quaternary ammonium salt.

4. The process according to claim 3 wherein the additive reagent is a quaternary ammonium chloride salt.

5. The process according to claim 4 wherein the quaternary ammonium chloride salt is selected from the group consisting of benzyltriethylammonium chloride, tetrabutylammonium chloride, tetraethylammonium chloride, and tetramethylammonium chloride.

6. The process according to claim 3 wherein the conversion is carried out in a solvent selected from the group consisting of acetonitrile, toluene, 2-methyl tetrahydrofuran, isopropyl acetate, acetone and methyl isobutyl ketone.

7. The process according to claim 1 in which process step (b) comprises a decarboxylation of the compound of Formula (VI) or a salt thereof to form the compound of Formula (V) or a salt thereof

followed by esterification of the compound of Formula (V) or salt thereof to form the compound of Formula (IV) or a salt thereof

wherein R is C 1-4 alkyl; and thereafter cyclization of the compound of Formula (IV) or a salt thereof to form the compound of Formula (III) or a salt thereof.

8. The process according to claim 7 which comprises a decarboxylation in the presence of a base.

9. The process according to claim 8 wherein the base is triethylamine.

10. The process according to claim 7 wherein esterification is performed using methanol and hydrochloric acid.

11. The process according to claim 7 wherein cyclization is performed using potassium tert-butoxide.

12. The process according to claim 7 wherein the compound of Formula (III) or a salt thereof is acidified and isolated by precipitation with methylcyclohexane.

13. The process according to claim 1 in which process step (c) comprises the condensation of the compound of Formula (IX) or a salt thereof to form the compound of Formula (VIII) or a salt thereof

followed by addition of a malonic ester (R 1 O(O)C—CH 2 —C(O)OR 2 ) to form a compound of Formula (VII) or a salt thereof

wherein R 1 and R 2 are independently C 1-4 alkyl;

and thereafter hydrolysation of the compound of Formula (VII) or a salt thereof to form the compound of Formula (VI) or a salt thereof.

14. The process according to claim 13 wherein the condensation is performed using potassium or sodium hydroxide in methanol.

15. The process according to claim 13 wherein the malonic ester is diethyl malonate.

16. The process according to claim 1 in which step (a) (ii) further comprises the formation of an acetic acid solvate of the compound of Formula (I).

17. The process according to claim 1 wherein the process further comprises a step of recrystallization of the compound of Formula (I) or a salt thereof.

18. The process according to claim 17 wherein the recrystallization is carried out using methanol and water.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: US BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: DERMAVENT SCIENCES GMBH
Reel/Frame 069274/0101 →
SECURITY INTEREST Recorded Oct 27, 2023
From: DERMAVANT SCIENCES GMBH
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065371/0110 →
SECURITY INTEREST Recorded Oct 25, 2023
From: DERMAVANT SCIENCES GMBH
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065348/0541 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND AND THIRD ASSIGNOR'S EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 063405 FRAME: 0576. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jun 19, 2023
From: CALANDRA, NICHOLAS; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064020/0597 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND AND THIRD ASSIGNOR'S EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 063440 FRAME: 0514. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jun 19, 2023
From: DAVIS, TYLER ANDREW; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064024/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2023
From: SUDINI, RAVINDER REDDY; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064073/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2023
From: GLAXO GROUP LIMITED; GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 063409/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2023
From: CALANDRA, NICHOLAS; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 063405/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2023
From: DAVIS, TYLER ANDREW; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 063440/0514 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2023
From: ANDREWS, IAN PAUL; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 063988/0279 →
Continuity (5)
Continuation 17174566 · Feb 12, 2021
Continuation 16849346 · Apr 15, 2020
Continuation 16189268 · Nov 13, 2018
Provisional Application 62584192 · Nov 10, 2017
Related Publication 20230174445A1 · Jun 8, 2023
References Cited (75)
US 4515883A · Sasaki · 1985 [cited by applicant]
US 5068458A · Dales et al. · 1991 [cited by applicant]
US 5268517A · Kober et al. · 1993 [cited by applicant]
US 5478856A · Suzuki et al. · 1995 [cited by applicant]
US 5589506A · Hashimoto et al. · 1996 [cited by applicant]
US 5760277A · Naef et al. · 1998 [cited by applicant]
US 6410596B1 · Hopp et al. · 2002 [cited by applicant]
US 6552085B2 · Inman et al. · 2003 [cited by applicant]
US 6624197B1 · Nag et al. · 2003 [cited by applicant]
US 6689922B1 · Bernardon · 2004 [cited by applicant]
US 7321050B2 · Chen et al. · 2008 [cited by applicant]
US 7868047B2 · Chen et al. · 2011 [cited by applicant]
US 8487009B2 · Chen et al. · 2013 [cited by applicant]
US 9308239B2 · Thiboutot et al. · 2016 [cited by applicant]
US 10195160B2 · Sonti et al. · 2019 [cited by applicant]
US 10376475B2 · Cote-Sierra et al. · 2019 [cited by applicant]
US 10426743B2 · Sonti et al. · 2019 [cited by applicant]
US 10647649B2 · Andrews et al. · 2020 [cited by applicant]
US 10961175B2 · Andrews et al. · 2021 [cited by applicant]
US 11617724B2 · Sonti et al. · 2023 [cited by applicant]
US 20030073712A1 · Wang et al. · 2003 [cited by applicant]
US 20110144212A1 · Subbaraju et al. · 2011 [cited by applicant]
CA 2266763A1 · 1999 [cited by applicant]
CN 101531571A · 2009 [cited by applicant]
CN 101564537B · 2011 [cited by applicant]
CN 101648851B · 2012 [cited by applicant]
CN 103172497A · 2013 [cited by applicant]
CN 104003848A · 2014 [cited by applicant]
CN 103992212B · 2015 [cited by applicant]
CN 105884581A · 2016 [cited by applicant]
CN 2017019159318 · 2017 [cited by applicant]
EP 0170105A2 · 1986 [cited by applicant]
EP 0334119B1 · 1993 [cited by applicant]
FR 1442295A · 1966 [cited by applicant]
GB 1465661A · 1977 [cited by applicant]
JP S5721341A · 1982 [cited by applicant]
JP S58159410A · 1983 [cited by applicant]
JP H0753359A · 1995 [cited by applicant]
JP H1072330A · 1998 [cited by applicant]
JP 2001261585A · 2001 [cited by applicant]
JP 2009269910A · 2009 [cited by applicant]
WO 1992016486A1 · 1992 [cited by applicant]
WO 1999059561A2 · 1999 [cited by applicant]
WO 2001042231A2 · 2001 [cited by applicant]
WO 2004031117A1 · 2004 [cited by applicant]
WO 2019063002A1 · 2019 [cited by applicant]
Kronenwerth et al. Facile Synthesis of Cyclohexanediones and Dialkyiresorcinols—Bioactive Natural Products from Entomopathogenic Bacteria, Eur. J. Org. Chem. 8026-8028. (Year: 2014). [cited by examiner]
Ali et al. “New Method for Isometization of (Z)-Stilbenes into the (E)-Isomers Catalyzed by Diaryl Disulfide” 1992, CA 118:233541, Chemical and Pharmaceutical Bulletin 40(10):3 Pages. [cited by applicant]
Ames et al. “Part III: Alkaline Hydrolysis of Ethyl 2:4-Dioxo-6-Styrylcyclohexanecarboxylate” 1958, Notes, J. Chemical Society 181:911-912. [cited by applicant]
Bezou et al. “Efficient Synthesis of p-Vinyl-Trans-Stilbene” Apr. 1996, Synthesis, 449-451. [cited by applicant]
Bissonnette et al. “Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Moderate Psoriasis: Results from a Randomized Double-Blind Placebo-Controlled, Phase II Trial” 2012, J. European Academy of Dermatolog… [cited by applicant]
Bissonnette et al. “Efficacy and Safety of Topical WBI-1001 in Patients with Mild to Severe Atopic Dermatitis: Results from a 12-Week, Multicentre, Randomized, Placebo-Controlled Double-Blind Trial” 2012, British Associ… [cited by applicant]
Bissonnette et al. “Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial” Apr. 2010, Reprinted in Archives of Dermatology … [cited by applicant]
Christensen et al. “Excelsaoctaphenol, A Stilbene Dimer From Chlorophora Excelsa” 1989, Phytochemistry Caplus 111:54148, 3 Pages. [cited by applicant]
Cushman et al. “Synthesis and Evaluation of Analogues of (Z)-1-(4-Methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) ethene as Potential Cytotoxic and Antimitotic Agents” Jun. 26, 1992, J. Medicinal Chemistry 352293-2306. [cited by applicant]
Delle Monache et al. “Isolation and Structure of Longistylin A, B, C, D and Other New Prenylated Stilbenes From Lonchocarpus Violaceus” 1977, CA 87:117649, 2 Pages. [cited by applicant]
Dudek et al. “Synthesis of Ferrocenethiols Containing Oligo(phenylenevinylene) Bridges and Their Characterization on Gold Electrodes” 2001, J. American Chemical Society 123(33):8033-8038. [cited by applicant]
Eicher et al. “Synthese Von Bryophyten-Inhaltsstoffen 2. Synthesen von prenylierten Bibenzyl-Derivaten” 1991, Synthesis 30:98-102. [cited by applicant]
Erdtman et al. “Bromination Products of 3, 5-dimethoxystilbene” 1949, CAPLUS 43:4524, 02 Pages. [cited by applicant]
Fang et al. “Flavonoids and Stilbenes from Armand Pine” May 20, 1988, Phyto Chemistry 27(5):1395-1397. [cited by applicant]
Gao et al. “Preparation of Chitosan Microspheres Loading of 3,5-dihydroxy-4-i-propylstilbene and In Vitro Release” Jan. 6, 2011, J . Polymer Research 18:1501-1508. [cited by applicant]
International Search Report and Written Opinion for PCT/US2018/060749 dated Jan. 18, 2019, 08 Pages. [cited by applicant]
Joseph et al. “Improved Preparation of 2,5-Dimethyl-1,3-Cyclohexanedione” 1995, Organic Preparations and Procedures International 27(4):499-500, ISSN 0004613633. [cited by applicant]
Kronenwerth et al. “Bioactive Derivatives of Isopropylstilbene from Mutasynthesis and Chemical Synthesis” Oct. 24, 2014, Chembiochem 15(18):2689-2691, DOI:10.1002/cbic.201402447, ISSN 1439-4227, XP055825654. [cited by applicant]
Krow et al. “Synthesis of Antibiotic Stillbenes Using Organomanganese Arene Complexes” 1992, The J. Organic Chemistry 57(14):4040-4043. [cited by applicant]
Leraux et al. “Condensation of Aldehydes AlphaBeta Unsaturates on Saturated Cetones” 1968, 14th Ed. Annals of Chemistry and Physics, 21 Pages. [cited by applicant]
Majima et al. “Cis-trans Isomerization and Oxidation of Radical Cations of Stilbene Derivatives” 1996, The J. Organic Chemistry 61:7793-7800. [cited by applicant]
Marta et al. “Synthesis of longistylin A, B, C, D and Other New Prenylated Stilbenes” 1980, CA 92:11061(2 Pages). [cited by applicant]
Ney et al. “Anti-inflammatory Effects of Synthetic Effects of Synthetic Retinoids may be Related to their Immunomodulatory Action” 1987, Dermatologica. 175(1):93-99. [cited by applicant]
Poldy et al. “Pheromones and Analogs from Neozeleboria Wasps and the Orchids that Seduce them: A Versatile Synthesis of 2,5-Dialkylated 1,3-Cyclohexanediones” Feb. 13, 2008, Tetrahedron Letters, Elsevier, Amsterdam, NL,… [cited by applicant]
Schamp et al. “New Synthesis of 2-Substituted Resorcinols” Jan. 1, 1973, Tetrahedron, Elsevier Sience Publishers, Amsterdam, NL, 29(23):3857-3859, DOI: 10.1016/0040-4020(73)80207-8, ISSN 0040-4020, XP026636606. [cited by applicant]
Third Party Observations for Israeli Patent Application No. 274439 submitted on Jul. 27, 2021, 4 pages. [cited by applicant]
Third Party Observations Submitted on Jul. 27, 2021 in European Patent Application No. 18875722.3, 4 Pages. [cited by applicant]
Zafiriadis et al. “Raney Nickel Hydrogenation of Cinnamal-Methylisobutyl ketone” Jan. 17, 1949, Weekly Reports of the Sessions of the Academy of Sciences 228:4 Pages, ISSN 0001-4036, (with English Abstract). [cited by applicant]
Zhang et al. “The Preparation of 3,5-Dihydroxy-4-Isopropylstilbene Nanoemulsion and In Vitro Release” 2011, International Journal of Nanomedicine 6:649-657. [cited by applicant]